•  
  •  
  •  
  •  

2025-10-01 19:38:53

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Hero MotoCorp Ltd dispatches 687,220 units in September 2025
  • Synbiotics Ltd's Amphotericin B Manufacturing Facility receives USFDA approval
  • Veefin has successfully integrated CRIF's Strategy One BRE with our no-code Digital Lending Stack
  • Sentynl Therapeutics updates on its NDA for CUTX-101
  • Unimech Aerospace and Manufacturing Ltd experiences slowdown in revenue

Keywords Selected:  RPGLifeSciences

Stock Report

  • RPG Life Sciences Ltd Q1 FY2026 PAT slips to Rs. 26.29 crores
  • RPG Life Sciences Limited recommends final dividend of Rs. 20
  • RPG Life Sciences Ltd Q4 FY2025 net profit at Rs. 117.35 crores
  • RPG Life Sciences Ltd Q3 FY2025 PAT surges to Rs. 34.93 crores
  • Fire at the manufacturing plant of RPG Life Sciences Limited located at Navi Mumbai
  • RPG Life Sciences Ltd Q1 FY25 PAT soars to Rs. 26.76 crores
  • RPG Life Sciences Ltd recommends dividend of Rs. 16
  • RPG Life Sciences Ltd Q4 FY2024 PAT falls QoQ to Rs. 13.24 crores
  • RPG Life Sciences Ltd Q3 FY24 net profit higher at Rs. 26.46 crores
  • RPG Life Sciences Ltd Q2 FY2024 PAT increases to Rs. 25.86 crores
  • RPG Life Sciences Ltd Q1FY24 net profit up at Rs. 22.10 crores
  • RPG Lifesciences Ltd recommends dividend of Rs. 12
  • RPG Life Sciences Ltd Q4FY23 PAT declines QoQ to Rs. 10.35 crores
  • RPG Life Sciences Ltd Q3 FY2023 net profit at Rs. 19.11 crores
  • RPG Life Sciences Ltd posts PAT of Rs. 19.97 crores in Q2FY23
  • RPG Life Sciences Ltd posts surge in Q1 FY23 net profit to Rs. 18.21 crores
  • RPG Life Sciences Limited recommends dividend of Rs. 9.60
  • RPG Life Sciences Q4FY22 net profit drops QoQ to Rs. 7.52 crores

Latest Post

  • Hero MotoCorp Ltd dispatches 687,220 units in September 2025
  • Synbiotics Ltd's Amphotericin B Manufacturing Facility receives USFDA approval
  • Veefin has successfully integrated CRIF's Strategy One BRE with our no-code Digital Lending Stack
  • Sentynl Therapeutics updates on its NDA for CUTX-101
  • Unimech Aerospace and Manufacturing Ltd experiences slowdown in revenue


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024